Structural Integrity of Nucleolin Is Required to Suppress TDP-43-Mediated Cytotoxicity in Yeast and Human Cell Models

The Transactivating response (TAR) element DNA-binding of 43 kDa (TDP-43) is mainly implicated in the regulation of gene expression, playing multiple roles in RNA metabolism. Pathologically, it is implicated in amyotrophic lateral sclerosis and in a class of neurodegenerative diseases broadly going under the name of frontotemporal lobar degeneration (FTLD). A common hallmark of most forms of such diseases is the presence of TDP-43 insoluble inclusions in the cell cytosol. The molecular mechanisms of TDP-43-related cell toxicity are still unclear, and the contribution to cell damage from either loss of normal TDP-43 function or acquired toxic properties of protein aggregates is yet to be established. Here, we investigate the effects on cell viability of FTLD-related TDP-43 mutations in both yeast and mammalian cell models. Moreover, we focus on nucleolin (NCL) gene, recently identified as a genetic suppressor of TDP-43 toxicity, through a thorough structure/function characterization aimed at understanding the role of NCL domains in rescuing TDP-43-induced cytotoxicity. Using functional and biochemical assays, our data demonstrate that the N-terminus of NCL is necessary, but not sufficient, to exert its antagonizing effects on TDP-43, and further support the relevance of the DNA/RNA binding central region of the protein. Concurrently, data suggest the importance of the NCL nuclear localization for TDP-43 trafficking, possibly related to both TDP-43 physiology and toxicity.

Nucleolin Rescues TDP-43 Toxicity in Yeast and Human Cell Models

TDP-43 is a nuclear protein involved in pivotal processes, extensively studied for its implication in neurodegenerative disorders. TDP-43 cytosolic inclusions are a common neuropathologic hallmark in amyotrophic lateral sclerosis (ALS) and related diseases, and it is now established that TDP-43 misfolding and aggregation play a key role in their etiopathology. TDP-43 neurotoxic mechanisms are not yet clarified, but the identification of proteins able to modulate TDP-43-mediated damage may be promising therapeutic targets for TDP-43 proteinopathies. Here we show by the use of refined yeast models that the nucleolar protein nucleolin (NCL) acts as a potent suppressor of TDP-43 toxicity, restoring cell viability. We provide evidence that NCL co-expression is able to alleviate TDP-43-induced damage also in human cells, further supporting its beneficial effects in a more consistent pathophysiological context. Presented data suggest that NCL could promote TDP-43 nuclear retention, reducing the formation of toxic cytosolic TDP-43 inclusions.

CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis

BACKGROUND

Epidemiological and clinical studies show higher prevalence of amyotrophic lateral sclerosis (ALS) in males than in females and more severe lesions in androgen receptor (AR)-expressing tissues. The AR gene contains a polymorphic CAG trinucleotide repeat, whose expansion over a certain threshold is toxic to motor neurons, causing spinal and bulbar muscular atrophy (SBMA).

PURPOSE AND METHODS

We tested the hypothesis that the AR CAG repeat linked to SBMA is a risk factor for ALS. We analyzed AR CAG expansions in 336 patients with ALS and 100 controls.

RESULTS

We found a negative association of AR CAG expansions with ALS susceptibility, clinical presentation, and survival.

CONCLUSIONS

Our findings do not support a role of the AR CAG repeat length in ALS.

Molecular evidence for nitric oxide-mediated motor neuron development

The complex morphological, electrophysiological and molecular properties of the adult vertebrate nervous system emerge over an extended period in prenatal and early postnatal life. Numerous studies have shown that synaptic activity plays a key role in the postnatal acquisition of mature neuronal phenotype. The cellular and molecular mechanisms subserving activity-dependent development are largely unknown. Several lines of evidence suggest that a rise in intracellular Ca2+ as a consequence of synaptic activity may regulate neuronal differentiation through its interactions with calcium-activated signal transduction molecules such as calcium/calmodulin kinase type II, protein kinase C or nitric oxide synthase (NOS). The aim of the present study is to identify potential signal transduction events subserving postnatal motor neuron development. Here we show that NOS antagonists block the molecular maturation of motor neurons and this effect is likely to be mediated by a subpopulation of ventral horn cells that express NOS transiently during early postnatal life. These results suggest that the local production of nitric oxide within the ventral horn may contribute to a late phase in motor neuron differentiation.